Skip to main content
SpringerLink
Log in

Utilisation of Drugs for Diabetes Mellitus

  • Pharmacoepidemiology
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

This article reviews the data from drug utilisation research on antidiabetic agents, oral hypoglycaemics and insulin. Study methods specific to this type of pharmacoepidemiological research are discussed and critiqued. A brief overview of the sources of drug utilisation data is presented, followed by a review of specific pharmacoepidemiological investigations. We evaluate the usefulness of these studies in assessing true drug consumption, in evaluating comorbidity in diabetic patients and in measuring the prevalence of diabetes. International comparisons of antidiabetic drug utilisation, also reviewed and analysed, demonstrate wide variations in the use of hypoglycaemic agents, which have arisen for reasons which are unclear. Drug utilisation research thus far has been limited by the paucity of studies relating these variations in antidiabetic drug use to specific clinical outcomes. There is a need to expand the applications of research on the use of antidiabetic agents, including assessment of patterns of morbidity across geographic boundaries and over time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baum C, Kennedy DL, Knapp DE, Juergens JP, Faith GA. Prescription drug use in 1984 and changes over time. Medical Care 26: 105–114, 1988

    Article  PubMed  CAS  Google Scholar 

  • Bergman U. Utilization of antidiabetic drugs in the island of Götland, Sweden: agreement between wholesale figures and prescription data. European Journal of Clinical Pharmacology 14: 213–220, 1978

    Article  PubMed  CAS  Google Scholar 

  • Bergman U: International comparisons of drug utilization: use of antidiabetic drugs in seven European countries. In Bergman et al. (Eds). Studies in drug utilization: methods and applications, p. 147, WHO, Copenhagen, 1979

  • Bergman U, Elmes P, Halse M, Halvorsen T, Hood M, et al. The measurement of drug consumption: drugs for diabetes in Northern Ireland, Norway and Sweden. European Journal of Clinical Pharmacology 8: 83–89, 1975

    Article  PubMed  CAS  Google Scholar 

  • Bergman U, Grimsson A, Wahba AHW, et al. (Eds). Studies in drug utilization: European Series No. 8, WHO Regional Office for Europe, Copenhagen, 1979

  • Bergstrom I, Boethius G, Wiman F. Sjukdomspanorama utlast ur en lakemedelsregistrering. Lakartidningen 69: Suppl. IV 34–37, 1972

    PubMed  Google Scholar 

  • Carson JL, Strom BL, Morse ML. Medicaid data bases. In Strom (Ed.) Pharmacoepidemiology — the science of post-marketing drug surveillance, Vol. 14, pp. 173–188, Churchill Livingstone, New York, 1989

    Google Scholar 

  • Damsgaard EM. Prevalence and incidence of Type II diabetes in Denmark compared with other countries. Acta Endocrinologica 262 (Suppl.): 21–26, 1984

    Google Scholar 

  • Drury TF, Powell AL. Prevalence of known diabetes among Black Americans. National Center for Health Statistics, Advance Data No. 130, 1987 European Marketing Data and Statistics. Euromonitor Publications Ltd, London, 1973

    Google Scholar 

  • FDA Drug utilization in the US 1987. Ninth Annual Review, Food and Drug Administration, Rockville, 1988

  • Fontbonne A, Papoz L, Eschwege E. Drug sales data and prevalence of diabetes in France. Revue d’Epidémiologie et de Santé Publique 34: 100–105, 1986

    PubMed  CAS  Google Scholar 

  • Friedman GD. Kaiser Permanente Medical Care Program: Northern California and other regions. In Strom (Ed.) Pharmacoepidemiology — the science of post-marketing drug surveillance, Vol. 13, pp. 161–172, Churchill Livingstone, New York, 1989

    Google Scholar 

  • Griffiths K, McDevitt DG, Andrew M, Baksaas I, Helgeland A, et al. Therapeutic traditions in Northern Ireland, Norway and Sweden: I. diabetes. European Journal of Clinical Pharmacology 30: 513–519, 1986

    Article  PubMed  CAS  Google Scholar 

  • Griffiths K, McDevitt DG, Andrew M, Baksaas I, Lunde PKM, et al. Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. European Journal of Clinical Pharmacology 29: 1–8, 1985

    Article  PubMed  CAS  Google Scholar 

  • Harlow SC, Linett MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. American Journal of Epidemiology 129: 233–248, 1989

    PubMed  CAS  Google Scholar 

  • IMS Research Group. A special analysis of the National Disease and Therapeutics Index Service for the Pharmaceutical Industry, IMS America, Ambler, 1979

  • Isacson D, Stålhammar J. Prescription drug use among diabetics: a population study. Journal of Chronic Diseases 40: 651–660, 1987

    Article  PubMed  CAS  Google Scholar 

  • Jervell J. Antidiabetic drug. In Sakshaug et al. (Eds) Drug utilization in Norway during the 1970s: increases, inequalities, and innovations, Norwegian Medicinal Depot, Oslo, 1983

    Google Scholar 

  • Joner G, Søvik O. Incidence, age at onset, and seasonal variation of diabetes mellitus in Norwegian children, 1973–1977. Acta Paediatrica Scandinavica 70: 329–355, 1981

    Article  PubMed  CAS  Google Scholar 

  • Jones JK, Kennedy DL. Data sources and methods for ascertaining human exposure to drugs. Journal of Toxicology — Clinical Toxicology 21: 237–251, 1983

    Article  PubMed  Google Scholar 

  • Kennedy DL, Piper JM, Baum C. Trends in use of oral hypoglycemic agents 1964-1986. Diabetes Care 11: 558–562, 1988

    Article  PubMed  CAS  Google Scholar 

  • Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. American Journal of Epidemiology 108: 497–505, 1978

    PubMed  CAS  Google Scholar 

  • Lee D, Bergman U. Studies of drug utilization. In Strom (Ed.) Pharmacoepidemiology, p. 259, Churchill Livingstone, New York, 1989

    Google Scholar 

  • Lilja J. The nationalization of the Swedish pharmacies. Social Science and Medicine 24: 423–429, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lunde PKM, Andrew M. Baksaas I. Drug utilization — an instrument in drug research. In Kewitz et al. (Eds). Epidemio-logical concepts in clinical pharmacology, p.57, Springer-Verlag, Berlin, 1987

    Chapter  Google Scholar 

  • Melton LJ, Palumbo J, Chu CP. Incidence of diabetes mellitus by clinical type. Diabetes Care 6: 75–86, 1983

    Article  PubMed  Google Scholar 

  • NCHS. Vital and health statistics of the National Center for Health Statistics, No. 134, 1987a

  • NCHS. Highlights of drug utilization in office practice: National Ambulatory Medical Care Survey, 1985. National Center for Health Statistics, Advance Data No. 137, 1987b

  • Rendell M. Lassek WD, Ross DA, Smith C, Kernek S, et al. A pharmaceutical profile of diabetic patients. Journal of Chronic Diseases 36: 193–202, 1983

    Article  PubMed  CAS  Google Scholar 

  • Sagild U, Littauer J, Jespersen CS, Andersen S. Epidemiological studies in Greenland 1962–1964: I. diabetes mellitus in Eskimos. Acta Medica Scandinavica 179: 29–39, 1966

    Article  PubMed  CAS  Google Scholar 

  • Serradell J, Bjornson DC, Hartzema AG. Drugs utilization study methodologies: national and international perspectives. Drug Intelligence and Clinical Pharmacy 21: 994–1001, 1987

    PubMed  CAS  Google Scholar 

  • Sjöqvist F, Agenäs I (Eds). Drug utilization studies: implications for medical care. Acta Medica Scandinavica 683: 1, 1984

  • Staff AC, Baksaas I. An estimation of the prevalence of diabetes mellitus in Norway: a prescription registration study. Scandinavian Journal of Primary Health Care 6: 233–237, 1988

    Article  PubMed  CAS  Google Scholar 

  • Stanulović M, Jakovljević V, Kovač T, Lepšanović L, Dučić M. Regional and international comparison in utilization of anti-diabetic drugs. International Journal of Clinical Pharmacology Therapy and Toxicology 24: 254–256, 1986

    Google Scholar 

  • Štika L. Patterns in drug utilization — national and international aspects: antidiabetic drugs. Acta Medica Scandinavica 683 Suppl: 53–57, 1984

    PubMed  Google Scholar 

  • Stergachis A. Group Health Cooperative of Puget Sound, Medicaid data bases. In Strom (Ed.) Pharmacoepidemiology — the science of post-marketing drug surveillance, Vol. 12, pp. 149–160, Churchill Livingstone, New York, 1989

    Google Scholar 

  • Stolley PD. The problem of drug utilization and the role of the WHO, DEM/75.5, World Health Organization, Geneva, 1975

    Google Scholar 

  • Strand LM, West R. Health data bases in Saskatchewan. In Strom (Ed.) Pharmacoepidemiology — the science of post-marketing drug surveillance, Vol. 15, pp. 189–200, Churchill Livingstone, New York, 1989

    Google Scholar 

  • University Group Diabetes Program. A study of the effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: I. Design, methods and baseline results. Diabetes, 19 (Suppl. 2): 747–783, 1970

    Google Scholar 

  • USDC. Pharmaceutical preparations, except biologicals. Current Industrial Reports: US Department of Commerce, Bureau of the Census, 1986

  • Zimmet P, Seluka A, Collins J, Currie P, Wiching J, et al. Diabetes mellitus in an urbanized, isolated Polynesian population: the Funafuti survey. Diabetes 26: 1101–1108, 1977

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Epidemiology Unit, Section of General Internal Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Nursing Education Bldg, 332R, Philadelphia, Pennsylvania, 19104-6095, USA

    Harold I. Feldman & Brian L. Strom

Authors
  1. Harold I. Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian L. Strom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feldman, H.I., Strom, B.L. Utilisation of Drugs for Diabetes Mellitus. Drug-Safety 6, 220–229 (1991). https://doi.org/10.2165/00002018-199106030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199106030-00006

Keywords

Search

Navigation